TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Pharmaceutical Excipient Albumin market was valued at US$ 167.1 million in 2023 and is projected to reach US$ 227.3 million by 2030, at a CAGR of 4% during the forecast period.
The USA market for Global Pharmaceutical Excipient Albumin market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Pharmaceutical Excipient Albumin market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Pharmaceutical Excipient Albumin market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Human Serum Albumin Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Excipient Albumin include CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion and LFB Group, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipient Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipient Albumin. This report contains market size and forecasts of Pharmaceutical Excipient Albumin in global, including the following market information:
Global Pharmaceutical Excipient Albumin Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Pharmaceutical Excipient Albumin Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Pharmaceutical Excipient Albumin companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Excipient Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceutical Excipient Albumin Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pharmaceutical Excipient Albumin Market Segment Percentages, by Type, 2023 (%)
Global Pharmaceutical Excipient Albumin Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pharmaceutical Excipient Albumin Market Segment Percentages, by Application, 2023 (%)
Global Pharmaceutical Excipient Albumin Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Pharmaceutical Excipient Albumin Market Segment Percentages, By Region and Country, 2023 (%)
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Excipient Albumin, market overview.
Chapter 2: Global Pharmaceutical Excipient Albumin market size in revenue and volume.
Chapter 3: Detailed analysis of Pharmaceutical Excipient Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Excipient Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharmaceutical Excipient Albumin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
